Cannabics Pharmaceuticals Inc. announced that it has appointed Dr. Erez Scapa to its Scientific Board of Advisors. Dr. Scapa, an Expert in Invasive Gastroenterology in the Sourasky Medical Center in Tel-Aviv, Israel, will join the company's scientific board of advisors, moving forward with the clinical validation of the safety and efficacy of the company's novel cannabis formulations for the treatment of colon cancer. Dr. Scapa joins Prof. Amos Toren and Prof. Zamir Halpern on the company's scientific advisory board, further strengthening the company's oncological expertise.